Bacterial endocarditis prophylaxis.
Bacterial endocarditis (BE) is a disease resulting from the association of morphological alterations of the heart and bacteraemia originating from different sources that at times can be indiscernible (infectious endocarditis). It is classified on the basis of the morphological alteration involved, depending on the clinical manifestations and course of illness, which varies according to the causative microorganism and host conditions (for example, it is characteristic in I.V. drug users). The most common microorganisms involved are: Streptococcus viridans (55%), Staphylococcus aureus (30%), Enterococcus (6%) and HACEK bacteria (corresponding to the initials: Haemophilus, Actinobacillus, Cardiobacterium, Eikenella and Kingella), although on occasions it can also be caused by fungi. The oral microbiological flora plays a very important role in the aetiopathogenesis of BE, given that the condition may be of oral or dental origin. This paper will deal with the prevention of said bacteraemia. Prophylaxis will be undertaken using amoxicillin or clindamycin according to action protocols, with special emphasis placed on oral hygiene in patients with structural defects of the heart.
Blanco-Carrión
Andrés
A
Departamento de Estomatología, Facultad de Medicina y Odontología, Universidad de Santiago de Compostela. Ablancoc@infomed.es
D000658:Amoxicillin / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D019072:Antibiotic Prophylaxis; D016470:Bacteremia / Q000150:complications / Q000517:prevention & control; D002981:Clindamycin / Q000627:therapeutic use; D017742:Dental Care for Chronically Ill; D004697:Endocarditis, Bacterial / Q000209:etiology / Q000382:microbiology* / Q000517:prevention & control*; D006801:Humans; D019647:Oral Surgical Procedures / Q000009:adverse effects*
D000900:Anti-Bacterial Agents; D002981:Clindamycin; D000658:Amoxicillin